Higher levels of IL-1ra, IL-6, IL-8, MCP-1, MIP-3α, MIP-3β, and fractalkine are associated with 90-day mortality in 132 non-immunomodulated hospitalized patients with COVID-19.
Liv Rabøl AndersenBettina HindsbergerSimone Bastrup IsraelsenLise PedersenPal Bela SzecsiThomas BenfieldPublished in: PloS one (2024)
We showed that one anti-inflammatory cytokine, one pro-inflammatory cytokine, and five chemokines were associated with 90-day mortality in patients hospitalized with COVID-19 that did not receive immunomodulatory therapy.
Keyphrases
- end stage renal disease
- anti inflammatory
- cardiovascular events
- coronavirus disease
- ejection fraction
- newly diagnosed
- sars cov
- chronic kidney disease
- rheumatoid arthritis
- risk factors
- prognostic factors
- peritoneal dialysis
- stem cells
- type diabetes
- cardiovascular disease
- mesenchymal stem cells
- cell therapy
- patient reported
- respiratory syndrome coronavirus